Point-of-Care (POC) Coagulation Testing Devices Market Insights On Growth Drivers, Trends, And Opportunities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Point-of-Care (POC) Coagulation Testing Devices Market Progress Between 2026 And 2030?
The market size for point-of-care (poc) coagulation testing devices has seen substantial growth in recent years. It is forecast to increase from $2.32 billion in 2025 to $2.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The historical expansion in this market can be linked to the increasing occurrence of coagulation disorders, the expanded use of anticoagulant therapies, the development of decentralized healthcare settings, the growing acceptance of point-of-care diagnostics, and enhancements in coagulation testing technologies.
The point-of-care (poc) coagulation testing devices market size is anticipated to experience robust expansion in the coming years. It is forecast to grow to $3.49 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.2%. The expected growth during this period stems from factors such as increasing demand for home healthcare diagnostics, a rising emphasis on personalized medicine, the expansion of telehealth-enabled diagnostics, a growing geriatric population, and continuous innovation in microfluidic testing platforms. Prominent trends observed in the forecast period include the increasing adoption of portable coagulation monitors, a rising demand for rapid diagnostic testing at the point of care, the growing use of home-based coagulation testing kits, the expansion of wireless data connectivity in poc devices, and an enhanced focus on test accuracy and reliability.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Factors Are Driving The Point-of-Care (POC) Coagulation Testing Devices Market Growth?
An increasing incidence of blood clotting disorders is anticipated to fuel the expansion of the point-of-care (POC) coagulation testing devices market moving ahead. These conditions hinder the blood’s natural capacity to form clots effectively. Certain lifestyle elements, such as smoking, heavy alcohol intake, and insufficient physical activity, can contribute to the development of blood clotting disorders. Such behaviors may detrimentally impact blood vessel integrity, levels of clotting factors, and circulation, thereby elevating the likelihood of irregular clot formation. With POC coagulation testing devices, healthcare professionals can rapidly evaluate a patient’s coagulation status, which facilitates prompt modifications to medication dosages and therapeutic strategies. As an illustration, the National Blood Authority, an Australia-based blood management agency, reported in July 2025 that the number of patients with hereditary haemophilia A (HMA) reached 2,788 in 2023–2024, an increase from 2,681 patients in 2022–2023. Consequently, the escalating occurrence of blood clotting disorders is a significant factor driving the growth of the point-of-care (POC) coagulation testing devices market.
What Are The Key Segment Divisions In The Point-of-Care (POC) Coagulation Testing Devices Market Segment Structure?
The point-of-care (poc) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Coagulation Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Which Trends Are Guiding The Direction Of The Point-of-Care (POC) Coagulation Testing Devices Market?
Leading companies within the point-of-care (POC) coagulation testing devices market are engaged in the development of immunofluorescence-based quantitative analyzers to enhance the diagnosis and management of coagulation disorders. These diagnostic instruments are employed in laboratory settings to measure and quantify specific proteins or molecules involved in the coagulation process, thereby assisting in the identification and control of blood clotting disorders. For example, in January 2023, Cipla Limited, an India-based pharmaceutical company, introduced Cippoint. This immunofluorescence-based quantitative analyzer leverages immunofluorescence technology to yield rapid and accurate test results within 3 to 15 minutes, which aids in quicker clinical decision-making. Featuring a user-friendly interface, swift turnaround time, and extensive testing capabilities, Cippoint is instrumental in improving diagnostic efficiency, enabling timely clinical judgments, and enhancing patient care outcomes.
Which Organizations Are Engaged In The Point-of-Care (POC) Coagulation Testing Devices Market?
Major companies operating in the point-of-care (poc) coagulation testing devices market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, Axis-Shield Diagnostics
Get The Full Point-of-Care (POC) Coagulation Testing Devices Market Report:
Which Geographic Region Dominates The Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2025. The regions covered in the point-of-care (poc) coagulation testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Point-of-Care (POC) Coagulation Testing Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Devices Market 2026, By The Business Research Company
Point Of Care Poc Coagulation Testing Devices Market Report 2026
Point Of Care Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Coagulation Markers Market Report 2026
https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
